Seeking Alpha
View as an RSS Feed

KarinCA  

View KarinCA's Comments BY TICKER:
Latest  |  Highest rated
  • Advanced Cell Technology's Intellectual Property Takes A Hit [View article]
    DWD Investing... the following cited work from the first sentence of this article has been discredited:

    Nature article:
    http://bit.ly/1HehbSB

    Scientist Resigns as Stem-Cell Creation Method Is Discredited
    http://bit.ly/1HehcWF

    I'm thinking this article may have been written before the Obokata work was discredited.
    Mar 29, 2015. 08:45 PM | Likes Like |Link to Comment
  • Should You Cancel Your Phone, TV And Internet Service Contracts? [View article]
    Elliott... I don't bother going to stores unless I need to physically try something on. There have been times I'll buy two pairs of shoes if unsure of the size and simply return the pair that doesn't fit. I only do this if in a hurry.

    90% of my shopping is done online with the vast majority of it from Amazon. With Amazon prime I get free shipping and most of Amazon prime entertainment for free. All for $99 annually. It's impossible to watch all available to me via Netflix, Amazon Prime and Youtube. The savings is unbelievable. My cost for the setup is a onetime fee for the hotspot app $7.95, Amazon Prime onetime fee of $99, and $8 monthly for Netflix. My Amazon Prime fee has been returned many times over due to the free shipping it gives me. I get daily packages and if I agree to one week shipping instead of 2 day they give me $1 credit in my account.

    I'm looking at a farmer that delivers boxes of vegetables once a week to try and eliminate the grocery store.

    I know many that pay the cell phone company a monthly fee for hotspot usage, but, that's not even needed with an app.

    Just make sure your smart phone is at least 4g for everything to work right. ;)
    Mar 16, 2015. 06:04 PM | 1 Like Like |Link to Comment
  • Should You Cancel Your Phone, TV And Internet Service Contracts? [View article]
    Interestingly, I live between two locations and am in the midst of testing whether or not I can live without my cable service in one of them. I run with my cell phone as a hotspot in my newest location and have found my internet and tv work perfectly fine without cable. My tv is a smart one and I have all the apps I need on it and don't miss cable at all.

    My cell phone plan has unlimited data usage and I use an app for the hotspot usage for free after a one time charge of $7.95. It's working so well off my cell phone I'm seriously considering canceling cable services at my primary location too.

    My second location is up in the mountains with no cable access. I was forced to find another solution and delighted with the results. ;)
    Mar 16, 2015. 02:15 PM | 2 Likes Like |Link to Comment
  • StemCells, Inc., And Neuralstem, Inc.: A Side-By-Side Analysis [View article]
    DWD Investing... I'm thinking you are asking for the CUR ALS trial link. Following is the phase 2 followed by the phase 1

    Neuralstem ALS studies
    http://1.usa.gov/1x1noRu

    “Official Title: A Phase II, Open-label, Dose Escalation and Safety Study of Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis

    Primary Outcome Measures:
    • To determine the safety of the maximum tolerated dose of human spinal cord-derived neural stem cell transplantation for the treatment of amyotrophic lateral sclerosis (ALS) assessed by the number and severity of adverse events. [ Time Frame: Patients will be followed postoperatively for 24 months. ] [ Designated as safety issue: Yes ]
    The primary objective of the study is to determine the feasibility, safety, toxicity, and maximum tolerated (safe) dose of human spinal cord-derived neural stem cell transplantation for the treatment of amyotrophic lateral sclerosis (ALS).

    Secondary Outcome Measures:
    • To evaluate neurologic deficits post spinal stem cell transplantation therapy. [ Time Frame: Patients will be followed postoperatively for 24 months. ] [ Designated as safety issue: Yes ]
    The secondary objectives of the study are to evaluate spinal stem cell transplantation therapy in this patient population for: 1) attenuation of motor function loss; 2) maintenance of respiratory capacity; 3) stabilization of ALSFRS-R; 4) reduction of spasticity/rigidity if present; and 5) graft survival at autopsy if and when there is mortality.”

    **********

    http://1.usa.gov/1x1nngF

    “Official Title: A Phase l, Open-label, First in Human, Feasibility and Safety Study of Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis

    Primary Outcome Measures:
    • The primary objective of this study is to determine the safety of human spinal cord-derived neural stem cell transplantation for the treatment of amyotrophic lateral sclerosis. [ Time Frame: The primary outcome measure will be assessed at study visits pre and post surgery follow-up visits, for a total of 48 months. ] [ Designated as safety issue: Yes ]
    The primary outcome measure is the incidence of adverse events in the study population.”

    See link for long list of Secondary Outcome Measures
    Mar 13, 2015. 11:19 AM | Likes Like |Link to Comment
  • An Interview With Cellceutix CEO Leo Ehrlich [View article]
    sparklshooz... the contract between Cellceutix and Harvard's Dana Farber is what determines what the company says about the Kevetrin phase I trial at this point. Not the FDA.
    Feb 26, 2015. 08:44 PM | 1 Like Like |Link to Comment
  • An Interview With Cellceutix CEO Leo Ehrlich [View article]
    mjl962... congrats on a good trade. You lucked out since biotech's like this are very volatile and it could have gone the other way. Bottom line, you did good. ;)

    Regarding phone numbers for CEO's. Do like I do and go to biotech conventions. You can meet the CEO's after the presentations in the Q&A and get their card. I have a three inch stack of cards I picked up last month at the convention in San Francisco. CEO's were all over the place that week since there were three biotech conventions in town at the same time. I even met some of them on the plane both to and fro. In the hotels, at breakfast. It was amazing how the place was flooded with biotech CEO's. Try it sometime. Do it regularly and you'll actually discover some things you may not have otherwise.

    Share price will do what it does as various catalysts come into play. I just present info for those that might want it.

    Anyway, good luck in all your trades.
    Feb 17, 2015. 10:59 PM | 7 Likes Like |Link to Comment
  • An Interview With Cellceutix CEO Leo Ehrlich [View article]
    Regarded Solutions... Thanks... That's quite the complement coming from you. ;)
    Feb 15, 2015. 07:39 PM | 1 Like Like |Link to Comment
  • An Interview With Cellceutix CEO Leo Ehrlich [View article]
    yunkolicious... That's a good question I'm unable to answer. I've been riding the ups and downs on this one for awhile now since I'm in for a long term play. Overall, it is up. Just pull up a three year weekly chart.
    Feb 12, 2015. 12:04 PM | 3 Likes Like |Link to Comment
  • Cellceutix Undervalued By 90+%; Expect A Short Squeeze Soon [View article]
    dpudvay... posted on company website today.

    $CTIX submitted an application to the NASDAQ Exchange for uplisting... http://bit.ly/1C8rdk5 ...
    Feb 8, 2015. 10:15 PM | 2 Likes Like |Link to Comment
  • Cellceutix Undervalued By 90+%; Expect A Short Squeeze Soon [View article]
    $CTIX submitted an application to the NASDAQ Exchange for uplisting...

    http://bit.ly/1C8rdk5
    Feb 8, 2015. 09:48 PM | 2 Likes Like |Link to Comment
  • Computer Task Group: With No Debt And A Growing Dividend, This Name Is Getting Too Cheap To Ignore [View article]
    mattgru... I'm looking at a chart of splits via my Fidelity account. All I see are forward splits on CTG, the most recent of which was a 2 for 1 in 1997. Next, I see a 3 for 2 in 1986. What am I missing?

    ValueArtifex ... nice article... just like nattypattyo said... I like reading about under the radar companies. ;)
    Feb 7, 2015. 03:50 PM | Likes Like |Link to Comment
  • Cellceutix Undervalued By 90+%; Expect A Short Squeeze Soon [View article]
    mjl962... you got me there. ;) I should have simply stated the probability is high that once a board is formed and the phase 3 results are in the price should be substantially higher. ;)

    Based on the two phase 2's, the probability of a successful phase 3 is 98%. Time will tell. ;)
    Feb 4, 2015. 04:49 PM | 2 Likes Like |Link to Comment
  • Cellceutix Undervalued By 90+%; Expect A Short Squeeze Soon [View article]
    dpudvay... I'm expecting your concerns to be addressed this year.
    Feb 2, 2015. 05:34 PM | 1 Like Like |Link to Comment
  • Cellceutix Undervalued By 90+%; Expect A Short Squeeze Soon [View article]
    djrryan... I'm not giving advice...just opinions. I happen to like CTIX. It's one of the few I'm holding in this crazy market. Most positions have been closed.
    Feb 2, 2015. 03:14 AM | 2 Likes Like |Link to Comment
  • Cellceutix Undervalued By 90+%; Expect A Short Squeeze Soon [View article]
    Small Pharma Analyst... Abacavir as a treatment for psoriasis came out of anecdotal experience of HIV patients who also suffered from the inflammatory disease. Most famously, Magic Johnson claimed that a benefit of his Abacavir treatment was the complete clearing up of his psoriasis.

    Clinically, this could not be duplicated sufficiently to warrant off-label usage. Plus, Abacavir has some side effects that limit its use for non-life threatening conditions. Prurisol is more than just a salt of Abacavir that converts to Abacavir in the system. Prurisol is a compound that includes the salt of Abacavir which minimizes side effects and the compound includes adjuvants for increased efficacy.

    Due to the crossover trial being successful, the Company will initiate a larger Phase 2 clinical trial under the 505(b)(2) designation. The FDA is permitting Prurisol to move to an advanced trial because the active moiety of Prurisol is that of a drug already approved by the FDA. This is a huge time saver.

    Just like the FDA granting Brilacidin QIDP status is a huge time saver along with adding another five years to the patent life. ;)
    Jan 31, 2015. 05:40 PM | 3 Likes Like |Link to Comment
COMMENTS STATS
414 Comments
705 Likes